Poor memory performance was associated with an increased risk for COVID-19 hospitalization and mortality in adults aged 50 years and older.

BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen, Inc., (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ...

Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...

Yearly Covid-19 Booster Recommendations in Canada, Europe, and Australia. Although the rapid development of multiple Covid-19 vaccines in 2020 represents a major scientific, medical, and regulatory ...

Award will support a 10,000-participant study comparing CyanVac’s PIV5-based intranasal vaccine candidate CVXGA with a commercial COVID-19 vaccine under BARDA’s Clinical Studies Network ATHENS, Ga. & ...

Houston-based Texas Medical Center has had challenges communicating data on its COVID-19 dashboard, and in some instances people are using the information to draw inaccurate conclusions. Without the ...

Patients hospitalized with COVID-19 were more likely to die than those hospitalized with influenza during the fall and winter of 2023-2024, according to an analysis of Veterans Affairs data. Among ...

After an in-depth analysis of the genetic material from hundreds of swabs taken from the walls, floors, machines and drains inside the Huanan Seafood Wholesale Market in Wuhan, China — a site that’s ...